Group One Trading’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-21,600
| Closed | -$2.2M | – | 8562 |
|
|
2023
Q2 | $2.2M | Sell |
21,600
-48,200
| -69% | -$4.56M | 0.01% | 1625 |
|
|
2023
Q1 | $6.35M | Buy |
69,800
+56,900
| +441% | +$3.34M | 0.02% | 714 |
|
|
2022
Q4 | $490K | Sell |
12,900
-74,800
| -85% | -$2.57M | ﹤0.01% | 3064 |
|
|
2022
Q3 | $2.2M | Buy |
87,700
+65,400
| +293% | +$1.81M | ﹤0.01% | 1830 |
|
|
2022
Q2 | $678K | Sell |
22,300
-10,700
| -32% | -$319K | ﹤0.01% | 3146 |
|
|
2022
Q1 | $1.08M | Buy |
33,000
+16,000
| +94% | +$475K | ﹤0.01% | 2996 |
|
|
2021
Q4 | $448K | Sell |
17,000
-21,400
| -56% | -$1.66M | ﹤0.01% | 4259 |
|
|
2021
Q3 | $3.86M | Buy |
38,400
+25,000
| +187% | +$2.93M | ﹤0.01% | 1975 |
|
|
2021
Q2 | $1.9M | Buy |
13,400
+5,300
| +65% | +$598K | ﹤0.01% | 2704 |
|
|
2021
Q1 | $808K | Buy |
8,100
+7,900
| +3,950% | +$921K | ﹤0.01% | 3491 |
|
|
2020
Q4 | $25K | Sell |
200
-3,400
| -94% | -$447K | ﹤0.01% | 5403 |
|
|
2020
Q3 | $351K | Sell |
3,600
-2,100
| -37% | -$262K | ﹤0.01% | 3168 |
|
|
2020
Q2 | $889K | Sell |
5,700
-14,400
| -72% | -$2.19M | ﹤0.01% | 2138 |
|
|
2020
Q1 | $2.9M | Buy |
20,100
+15,500
| +337% | +$2.99M | 0.02% | 810 |
|
|
2019
Q4 | $940K | Buy |
4,600
+3,600
| +360% | +$657K | 0.01% | 1942 |
|
|
2019
Q3 | $80K | Sell |
1,000
-200
| -17% | -$17K | ﹤0.01% | 3709 |
|
|
2019
Q2 | $113K | Hold |
1,200
| – | – | ﹤0.01% | 3261 |
|
|
2019
Q1 | $103K | Buy |
+1,200
| New | +$99.6K | ﹤0.01% | 3154 |
|
|
2018
Q4 | – | Sell |
-100
| Closed | -$8K | – | 5573 |
|
|
2018
Q3 | $8K | Hold |
100
| – | – | ﹤0.01% | 4728 |
|
|
2018
Q2 | $3K | Sell |
100
-100
| -50% | -$3.05K | ﹤0.01% | 4910 |
|
|
2018
Q1 | $4K | Buy |
+200
| New | +$5.15K | ﹤0.01% | 4567 |
|
Other funds holding RETA
Group One Trading's RETA Position: Q2 2023 in Review
Group One Trading sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q2 2023, closing a stake of 24,376 shares — an estimated $2.31M sold.
Group One Trading first reported a position in RETA in Q1 2018 and held it in 10 quarters. The position peaked at $2.22M in Q1 2023. 214 funds tracked by Wall St. Rank hold RETA as of Q2 2023.
- Group One Trading reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
- Group One Trading sold 24,376 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q2 2023, an estimated $2.31M.
- Group One Trading first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q1 2018 and held it in 10 quarters.
- Group One Trading's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $2.22M in Q1 2023.
- 214 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q2 2023.
Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.